基于中国PIM标准分析老年精神疾病住院患者潜在不适当用药现状

doi:10.3969/j.issn.1000-8535.2022.03.014

广州医药 ›› 2022, Vol. 53 ›› Issue (3): 57-61.DOI: 10.3969/j.issn.1000-8535.2022.03.014

基于中国PIM标准分析老年精神疾病住院患者潜在不适当用药现状

刘昀¹, 古美玲¹, 庄淑丽²

1 广州市老人院药房(广州 510550)
2 广州市民政局精神病院药剂科(广州 510430)

收稿日期:2021-06-24 出版日期:2022-05-20 发布日期:2022-07-01

Analysis of potentially inappropriate medication in elderly psychiatric inpatients based on criteria of potentially inappropriate medication for the elderly in China

LIU Yun¹, GU Meiling¹, ZHUANG Shuli²

1 Pharmacy,Home for the Aged Guangzhou,Guangzhou 510550,China
2 Pharmacy,Guangzhou Bureau of Civil Affairs Psychiatric Hospital,Guangzhou 510430,China

Received:2021-06-24 Online:2022-05-20 Published:2022-07-01

摘要/Abstract

摘要： 目的调查分析老年精神疾病住院患者潜在不适当用药(PIM)现状。方法回顾分析2021年3月老年住院患者临床诊断、用药情况等资料,依据2017年版《中国老年人潜在不适当用药判断标准》分析处方PIM情况。结果 125例研究对象中,平均年龄(73.31±7.87)岁,平均用药(6.62±2.68)种。101例(80.80%)患者存在140项PIM,81例(64.80%)患者使用了A级警示药物共103项,33例(40.74%)患者使用了B级警示药物共37项;高风险药物39项(27.86%),低风险药物101项(72.14%);PIM发生率排名前3位的药物是奥氮平、利培酮、劳拉西泮;12例患者存在4项与疾病状态相关的PIM。结论该院PIM发生率偏高,医生和药师应加大力度降低PIM比例,减少不良反应,提高用药安全,促进合理用药。

关键词: 潜在不适当用药, 老年精神疾病住院患者, 用药分析

Abstract: Objective To investigate the current status of potentially inappropriate medications (PIM) for elderly inpatients with mental illness in a psychiatric hospital. Methods Based on the 2017 edition of “Judgment Standards for Potentially Inappropriate Medications for the Elderly in China”, we retrospectively analyzed the PIM by investigating the clinical diagnosis and medication status of 125 elderly psychiatric inpatients in March 2021. Results Among 125 subjects, the average age was (73.31±7.87) years, and the average medication was (6.62±2.68). There were 101 patients (80.80%) had 140 items of PIM, 81 patients (64.80%) used a total of 103 items of A-level warning drugs, 33 patients (40.74%) used a total of 37 items of B-level warning drugs; there were 39 high-risk drugs(27.86%), 101 low-risk drugs (72.14%); the drugs with top three PIM incidence were olanzapine, risperidone and lorazepam; 12 patients had 4 PIMs related to the disease state. Conclusions The incidence of PIM in this hospital is relatively high. Doctors and pharmacists should be advised to increase their efforts to reduce the proportion of PIM, reduce the incidence of adverse reactions, improve medication safety, and promote rational drug usage.

Key words: potentially inappropriate medication, elderly psychiatric inpatients, drug analysis

刘昀, 古美玲, 庄淑丽. 基于中国PIM标准分析老年精神疾病住院患者潜在不适当用药现状[J]. 广州医药, 2022, 53(3): 57-61.

LIU Yun. Analysis of potentially inappropriate medication in elderly psychiatric inpatients based on criteria of potentially inappropriate medication for the elderly in China[J]. Guangzhou Medical Journal, 2022, 53(3): 57-61.

参考文献

[1] GALLAGHER P F,O'CONNOR M N,O'MAHON Y D.Prevention of potentially inappropriate prescribing for elderly patients:A randomized controlled trial using STOPP/START criterial[J].Clin Pharmacol Ther,2011,89(6):845-854.
[2] 中国老年保健医学研究会老年合理用药分会,中华医学会老年医学分会,中国药学会老年药学专业委员会,等.中国老年人潜在不适当用药判断标准(2017年版)[J].药物不良反应杂志,2018,20(1):2-8.
[3] 万晓娜,孙祥虹.对精神科老年住院患者用药情况的分析[J].当代医药论丛,2017,15(15):34-36.
[4] 赵丽莎,吴军红,郝爱荣,等.精神专科医院高龄老年患者门诊诊疗情况调查[J].中国全科医学,2020,23(S1):185-187.
[5] 杨明珠,李娜.老年人多重用药的认知管理研究进展[J].中国老年学杂志,2015,35(6):1715-1717.
[6] 中国老年医学研究会内分泌代谢分会,中国毒理学会临床毒理专业委员会.老年人多重用药安全管理专家共识[J].中国药物警戒,2018,15(10):627-640.
[7] 李莹,钱玉英,李耘,等.老年人多重用药及评价工具的研究进展[J].中华老年多器官疾病杂志,2021,20(3):229-232.
[8] 曲国红,智俊娜,陈龙保,等.老年患者多重用药风险及其影响因素分析[J].药学与临床研究,2020,2(85):363-366.
[9] 邵静,侯晓莹,黄婷婷,等.老年精神疾病患者多重用药现状研究[J].中华现代护理杂志,2019,25(8):975-979.
[10] 武兴荣.奥氮平与利培酮治疗老年精神分裂症患者的安全性对比[J].中国药物与临床,2020,20(21):3648-3650.
[11] 程雪君,谢转仪,甘静文,等.奥氮平对老年精神分裂症患者的疗效及糖脂代谢的影响[J].中国医药科学,2019,9(24):78-81.
[12] 黄承保,王小莉.奥氮平对老年精神分裂症患者的疗效及糖脂代谢的影响[J].中国临床医生杂志,2019,47(5):567-570.
[13] 刘夏,潘琴,徐迅科,等.基于《中国老年人潜在不适当用药判断标准(2017版)》的老年患者不适当用药评价研究[J].药学实践杂志,2019,37(3):283-288.
[14] 广东省药学会.老年人药物相关性跌倒预防管理专家共识[J].今日药学,2019,29(10):649-658.
[15] 梁英,刘登堂,司天梅,等.氨磺必利治疗精神分裂症临床应用专家意见[J].中国心理卫生杂志,2017,31(6):425-431.
[16] 班一峰.齐拉西酮与奥氮平治疗老年精神分裂症的效果[J].深圳中西医结合杂志,2020,30(1):128-129.
[17] 李春娟.帕利哌酮缓释片的临床研究进展[J].齐齐哈尔医学院学报,2018,39(6):700-702.
[18] 刘铁桥,赵敏.苯二氮䓬类药物临床使用专家共识[M].北京:人民卫生出版社,2016:18-26.
[19] 陈蛟,郁涛,黄文燕.老年精神病住院患者跌倒原因分析及防范[J].中国社区医师,2015,31(34):163-164.
[20] 中华医学会神经病学分会睡眠障碍学组.中国成人失眠诊断与治疗指南[J].中华神经科杂志,2018,51(5):324-335.
[21] 侯凯旋,邢晓璇,闫素英.中国老年住院患者潜在不适当用药现状研究[J].实用药物与临床,2018,21(1):88-93.
[22] 陈艳,侍羽,杨曼,等.药学干预对老年精神分裂症患者用药依从性和生活质量的影响[J].当代医学,2019,25(23):12-14.
[23] 吴源渊,谭宏韬,邹国涛.AIDET沟通模式在家庭签约社区老年糖尿病患者中的应用[J].现代医院,2021,21(7):1070-1072.
[24] 邱珊娇,唐干益,黄文静.Beers 标准(2019)和中国老年人潜在不适当用药判断标准(2017 版)评估社区老年共病患者的不适当用药分析[J].中国全科医学,2020,23(S1):34-38.

基于中国PIM标准分析老年精神疾病住院患者潜在不适当用药现状

Analysis of potentially inappropriate medication in elderly psychiatric inpatients based on criteria of potentially inappropriate medication for the elderly in China

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价